Capvizr
THE DEAL, AT A GLANCE

Aqemia

From the announcement
01Who is involvedBacked by Elaia, Omnes CapitalFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedAqemia raised $30M Series AFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersAqemia is applying statistical mechanics, quantum methods, and AI to drug design, with the Series A financing framed around advancing 3 drug programs in oncology and…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Aqemia · Financing Record

Explore source-linked visual explanations for Aqemia. Unsupported claims are withheld while source review continues.

Record 574 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 574 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime